Literature DB >> 6423391

Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.

G Sangster, S B Kaye, K C Calman, J F Dalton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6423391     DOI： 10.1016/0277-5379(84)90093-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  14 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.

Authors:  Gerald Schwerdt; Antje Kirchhoff; Ruth Freudinger; Brigitte Wollny; Andreas Benesic; Michael Gekle
Journal:  Pediatr Nephrol       Date:  2007-02-02       Impact factor: 3.714

3.  Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Authors:  M P Goren; C B Pratt; M J Viar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Hypophosphataemic rickets after ifosfamide treatment in children.

Authors:  R Skinner; A D Pearson; L Price; K Cunningham; A W Craft
Journal:  BMJ       Date:  1989-06-10

5.  Fanconi syndrome after ifosfamide.

Authors:  M Moncrieff; A Foot
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 6.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Nephrotoxicity after ifosfamide.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

8.  Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.

Authors:  Mohamed M Sayed-Ahmed; Amal Q Darweesh; Amal J Fatani
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

Review 9.  Dosing and side-effects of ifosfamide plus mesna.

Authors:  W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Nephrotoxicity associated with ifosfamide.

Authors:  J Smeitink; M Verreussel; C Schröder; R Lippens
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.